Firsthand Technology Value Fund Discloses Preliminary NAV

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Firsthand Technology Value Fund Discloses Preliminary NAV of $27.43 Per Share as of March 31, 2014

SAN JOSE, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (Nasdaq: SVVC ) (the "Fund"), a publicly-traded venture capital fund that invests in technology and cleantech companies, today disclosed its preliminary net asset value (NAV) of $27.43 per share, as of March 31, 2014.

The Fund also announced that its top five holdings as of March 31, 2014, were Twitter, Facebook, IntraOp Medical, Turn, and AliphCom.

  1. Twitter, Inc. (NYSE: TWTR ) is an online social networking service that lets users send and receive 140-character messages ("tweets"). As of March 31, 2014, the Fund's investment in Twitter consisted of 1,006,200 shares of common stock and represented approximately 17.0% of the Fund's preliminary net assets.
     
  2. Facebook, Inc. (Nasdaq: FB ) is an online social networking service with more than 1 billion monthly active users worldwide. As of March 31, 2014, the Fund's investment in Facebook consisted of 600,000 shares of common stock and represented approximately 14.5% of the Fund's preliminary net assets.
     
  3. IntraOp Medical, Inc. is the manufacturer of the Mobetron, a medical device that is used to deliver intra-operative radiation to cancer patients. As of March 31, 2014, the Fund's investment in IntraOp consisted of 20,300,000 shares of preferred stock and a debt security representing approximately 9.4% of the Fund's preliminary net assets.
     
  4. Turn Inc. is a leading provider of advertising technology to Fortune 1000 marketers and their agencies. As of March 31, 2014, the Fund's investment in Turn consisted of 1,798,562 shares of preferred stock and represented approximately 6.0% of the Fund's preliminary net assets.
     
  5. AliphCom, Inc. designs and markets wearable technology and audio devices under the Jawbone brand. As of March 31, 2014, the Fund's investment in AliphCom consisted of 2,128,005 shares of common stock and represented approximately 4.1% of the Fund's preliminary net assets.

The Fund's preliminary net assets as of March 31, 2014 also include cash of approximately $5.97 per share. As of that date, the Fund's top five holdings constituted 51.0% of the Fund's preliminary net assets. Complete financial statements and a detailed schedule of investments will be made available with the Fund's quarterly report filing on Form 10-Q in May 2014.

About Firsthand Technology Value Fund

Firsthand Technology Value Fund, Inc. is a publicly-traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com .

The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund's investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund's historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund's filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund's investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us.

Heather Hohlowski Firsthand Capital Management, Inc. (408) 624-9525

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 249

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 61

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 307

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 138

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 203

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 76

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 48

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 149

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 41

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 482

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Abeona Therapeutics' ZEVASKYN Receives FDA Approval, a New Hope

Updated Category News Views 147

A Revolutionary Breakthrough for Epidermolysis Bullosa In an incredible achievement for the EB community, Abeona Therapeutics has received FDA approval for ZEVASKYN, which is poised to change the landscape for treating Recessive Dystrophic Epidermolysis Bullosa (RDEB). This marks a historic moment as the third FDA-approved treatment for RDEB and the first autologous,...

Continue Reading
Zero Candida Reaches Major Milestone with ZC-001 Device Development

Updated Category News Views 127

Zero Candida Marks Milestone with ZC-001 Prototype Production Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) has achieved a remarkable milestone in its quest to revolutionize women's health. The company recently announced the commencement of prototype production for its groundbreaking therapeutic device, ZC-001, designed specifically for the treatment of...

Continue Reading
Bitcoin's Future and Market Dynamics: Insights from a Veteran Trader

Updated Category News Views 86

Cautious Optimism for Bitcoin and Other Cryptocurrencies Pseudonymous veteran trader DonAlt expresses a cautious outlook on leading cryptocurrencies like Bitcoin, Ethereum, and Dogecoin. His insights on market trends reveal an intriguing perspective for investors in these digital assets. Current Market Situation DonAlt has recently shared his thoughts on the performance...

Continue Reading
Alibaba Settles for $433.5 Million in Shareholder Lawsuit

Updated Category News Views 220

Alibaba Reaches Settlement in Lawsuit Alibaba (NYSE: BABA), China’s leading e-commerce powerhouse, has recently taken a significant step in addressing legal challenges by agreeing to pay $433.5 million to settle a class-action lawsuit in the United States. This lawsuit, brought forth by investors, accused Alibaba of engaging in monopolistic practices. The company's...

Continue Reading
Class Action Alert: Telix Pharmaceuticals Lawsuit Overview

Updated Category News Views 174

Understanding the Telix Pharmaceuticals Class Action In a significant development, investors of Telix Pharmaceuticals Limited are currently facing a class action lawsuit. This initiative, spearheaded by Bronstein, Gewirtz & Grossman LLC, invites those affected by substantial losses in their investments to take action. The law firm is renowned for its dedication in...

Continue Reading